RNA interference (RNAi) has emerged as a powerful tool for the sequence-specific silencing of mRNAs in eukaryotic cells [reviewed in (
1,
2)]. First discovered in plants and nematodes, it soon became clear that RNAi is conserved throughout the eukaryotic kingdom as a means of gene regulation and protection of an organism against parasites such as viruses and transposons [reviewed in (
3–
7)]. The machinery involved in RNAi consists of a complex mixture that includes a helicase, endo- and exonucleases and most likely—at least in the nematode
Caenorhabditis elegans—an RNA-directed RNA polymerase [reviewed in (
2)]. The endoribonuclease Dicer triggers RNAi response by the digestion of long double-stranded RNA (dsRNA) into small pieces of ~21 nt length that are referred to as small interfering RNAs (siRNAs). Invertebrates such as
C.elegans and
Drosophila melanogaster are able to effectively digest and therefore employ long pieces of dsRNA for dsRNA-based gene silencing. Several genome-wide RNAi screens have therefore been carried out successfully in these invertebrate model systems for the discovery of new genes in different cellular pathways (
8–
15). The introduction of long dsRNA into mammalian systems is, however, more problematic. This is due to the fact that in most mammalian cells dsRNA that is longer than 40 nt (Frank Buchholz, unpublished data) induces a nonspecific interferon response, leading to the general shutdown of transcription and/or cell death (
16,
17). Most standard protocols for RNAi in mammalian systems therefore use chemically synthesized siRNAs, and this method has emerged as a promising tool for sequence-specific gene silencing in mammalian cell culture (
18). Yet this approach is limited by the fact that different sequences within a gene have dramatically varied inhibitory abilities (
19). In essence, a large number of different synthetic siRNAs have to be screened for their efficacy at knocking down the gene of interest, which is a laborious and costly task. The applicability for high-throughput screens using chemically synthesized siRNAs is therefore questionable. An alternative approach employs long dsRNAs that have either been partially digested with
Escherichia coli RNaseIII to give a mixture of short siRNAs with lengths of 18–30 nt [endoribonuclease-prepared siRNAs (esiRNAs) (
20,
21)] or
in vitro digested by recombinant Dicer (
22,
23). The advantage of esiRNAs over synthetic siRNAs is that
in vitro digestion of long dsRNAs results in coverage of a larger portion of the endogenous mRNA. The chances of effective sequence-specific silencing therefore increase drastically. Since this method is very cost-effective, it will likely become an invaluable tool for high-throughput screening in mammalian systems (
24). Though less variable in their performance in gene silencing, esiRNAs are likely to be more susceptible to cross-silencing of homologous genes. Likewise, the current protocol for RNAi in the invertebrates
D.melanogaster and
C.elegans is susceptible to nonspecific silencing effects. This is due to the fact that random digestion of a large dsRNA leads to random siRNAs that will cross-react with any sequence identical to theirs. Even though there are contradictory reports on the problem of cross-silencing in RNAi (
25–
27), the possibility that siRNAs cross-silence genes that are identical in sequence to the intended target cannot be ruled out at this time. While the specificity of a single siRNA may be checked by a single sequence similarity search against the transcriptome or genome of the organism being studied, endoribonuclease preparation of long dsRNAs requires each potential siRNA to be analyzed for its specificity for the target, and possible cross-reactions with other genes must be excluded.
In this paper, we describe a new tool that has been specifically tailored to meet the needs of RNAi using endoribonuclease-prepared siRNAs. The program, called DEQOR, mimics esiRNAs by fragmenting the input sequence into pieces of 16–25 nt, whereby the sequence window is shifted along the input query by 1 nt at each iteration step of the algorithm. Subsequently, each
in silico siRNA is (i) analyzed using state-of-the-art parameters for its ability to induce sequence-specific gene silencing and (ii) analyzed for its ability to cross-silence genes different from the target by performing BLAST searches against the transcriptome or genome of the organism under study. DEQOR represents the first tool that enables researchers to analyze esiRNAs, and likewise synthetic siRNAs, for their quality in terms of induction of gene silencing and for their ability to cross-silence genes other than the target itself in a high-throughput manner. A web-based user interface makes the usage and the interpretation of results retrieved by DEQOR easy and straightforward. DEQOR can be accessed freely at
http://cluster-1.mpi-cbg.de/Deqor/deqor.html.